IL117795A - 6, 7-dihydro-3-(2-nitrophenyl) 1, 2-benzisoxazole-4(5h)-ones and pharmaceutically acceptable addition salts thereof - Google Patents
6, 7-dihydro-3-(2-nitrophenyl) 1, 2-benzisoxazole-4(5h)-ones and pharmaceutically acceptable addition salts thereofInfo
- Publication number
- IL117795A IL117795A IL117795A IL11779592A IL117795A IL 117795 A IL117795 A IL 117795A IL 117795 A IL117795 A IL 117795A IL 11779592 A IL11779592 A IL 11779592A IL 117795 A IL117795 A IL 117795A
- Authority
- IL
- Israel
- Prior art keywords
- hydrogen
- loweralkyl
- pharmaceutically acceptable
- addition salts
- nitrophenyl
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title claims abstract description 4
- GEUUYJJWODKICD-UHFFFAOYSA-N 3-(2-nitrophenyl)-6,7-dihydro-5h-1,2-benzoxazol-4-one Chemical class [O-][N+](=O)C1=CC=CC=C1C1=NOC2=C1C(=O)CCC2 GEUUYJJWODKICD-UHFFFAOYSA-N 0.000 title claims description 4
- -1 loweralkyl Inorganic materials 0.000 claims abstract description 13
- 150000001875 compounds Chemical class 0.000 claims abstract description 10
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 9
- 239000001257 hydrogen Substances 0.000 claims abstract description 7
- 239000002253 acid Substances 0.000 claims abstract description 6
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 4
- 150000002367 halogens Chemical class 0.000 claims abstract description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 4
- 230000003287 optical effect Effects 0.000 claims abstract description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims abstract description 3
- 150000002431 hydrogen Chemical class 0.000 claims abstract 4
- 150000001204 N-oxides Chemical class 0.000 claims abstract 2
- 238000000034 method Methods 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 230000007074 memory dysfunction Effects 0.000 abstract 1
- YLJREFDVOIBQDA-UHFFFAOYSA-N tacrine Chemical class C1=CC=C2C(N)=C(CCCC3)C3=NC2=C1 YLJREFDVOIBQDA-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- HUIVMWSIMINFRO-UHFFFAOYSA-N n-chloro-2-nitrobenzamide Chemical compound [O-][N+](=O)C1=CC=CC=C1C(=O)NCl HUIVMWSIMINFRO-UHFFFAOYSA-N 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Natural products C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000001589 carboacyl group Chemical group 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 1
- RAFYDKXYXRZODZ-UHFFFAOYSA-N octanoyl octanoate Chemical compound CCCCCCCC(=O)OC(=O)CCCCCCC RAFYDKXYXRZODZ-UHFFFAOYSA-N 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/08—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
- C07F7/0814—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/08—Nitrogen atoms
- C07D219/10—Nitrogen atoms attached in position 9
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/12—Organo silicon halides
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
The present invention relates to 9-amino-1,2,3,4-tetrahydroacridines and related compounds of formula 1 <CHEM> wherein Y ix C=0 or CHOH; R<1> is hydrogen or loweralkyl; R<2> is hydrogen, loweralkyl, or phenylloweralkyl; R<3> is hydrogen, OR<4> wherein R<4> is hydrogen or COR<5> wherein R<5> is loweralkyl, X is hydrogen, loweralkyl, halogen, loweralkoxy, hydroxy, or trifluoromethyl, the geometric or optical isomers thereof, N-oxides, thereof, or the pharmaceutically acceptable acid addition salts thereof, which are useful in relieving memory dysfunction and are thus indicated in the treatment of Alzheimer's disease. The invention relates further to a process for the preparation of the above compounds.
Description
117795/3 6,7 DIHYDRO-3-(2-NITROPHENYL) 1,2-BENZISOXAZOLE-4(5H)-ONES AND PHARMACEUTICALLY ACCEPTABLE ADDITION SALTS THEREOF ϋ"·]ΊΝ-(5Η) -"?πκυϊ?"ΐυΊΤ:α-2,1 (^Ί]9Τ"Ιϋ",]-2)-3-'ΠΤ,Π",7 7,6 TJ^NIEI TTTODTQ ττ'ριπριιπ TJ^DITD ΌΤΓΡΓΠ The present invention relates to dihydrobenzisoxazolines of formula 6. o wherein X is hydrogen, loweralkyl, halogen, loweralkoxy, hydroxy, or trifluoromethyl. The above compounds are valuable intermediates in organic synthesis , and especially for the preparation of compound s of copending patent application No, 100921 , from which the present application has been divided out.
As used throughout the specification and appended claims, the term "alkyl" refers to a straight or branched chain hydrocarbon radical containing no unsaturation and having I to 8 carbon atoms. Examples of alkyl groups are methyl, ethyl, I -propyl, 2-propyl, I -butyl, I -pentyl, 3-hexyl, 4-heptyl, 2-octyl and the like. The term "alkoxy" refers to a monovalent substituent which consists of alkyl goup linked through an ether oxygen having its free valence bond from the ether oxygen. Examples of alkoxy: groups are methoxy, ethoxy, propoxy, I -butoxy, I -pentoxy, 3-hexoxy, 4-heptoxy, 2-octoxy and the like. The term "alkanol" refers to a compound formed by a combination of an alkyl group and hydroxy radical. Examples of alkanols are methanol, ethanol, 1- and 2-propanol, 2,2-dimethylethanol, hexanol, octanol and the like. The term "alkanoic acid" refers to a compound formed by combination of a carboxyl group with a hydrogen atom or alkyl group. Examples of alkanoic acids are formic acid, acetic acid, propanoic'acid, 2,2-dimethylacetic acid, hexanoic acid, octanoic acid and the like. The term "halogen" refers to a member of the family fluorine, chlorine, bromine, or iodine. The term "alkanoyl" refers to the radical tonned by removal of the hydroxy function from an alkanoic acid. Examples of alkanoyl groups are formyl, acetyl, propionyl, 2,2-dimethylacetyl, hexanoyl, octanoyl, anhydride, octanoic acid anhydride and the like. The term "lower" as appl to any of the aforementioned groups refers to a group having a carbon skeleton containing up to and including 6 carbon atoms.
The present invention comprehends all optical isomers and recemic forms thereof of the compounds disclosed and claimed herein and the formulas of the compounds shown herein are intended to encompass all possible optical isomers of the compounds so depicted.
The novel dihydrobenzisoxazoiines of the present invention are prepared by the process delineated in Reaction Scheme A.
To prepare a dihydrobenzisoxazole β of the present invention, a 2-nitrobenzhydroxamic chloride 4 is condensed with a cyclohexan-1 ,3-dione enamine 5 to provide a 6, 7 - dihydro-3-(2-nitrophenyl)benzisoxazol-4(5H)-one 6, EXAMPLE 1 6,7-Dihydro-3-(2-nitrophenyl)-1,2-benzisoxazol-4(5H)-one To a solution of 1 ,3-cyclohexadione morpholine enamine (20.8 g), tetrahydrofuran, (150 ml), and triethylamine (2 ml) at reflux was added a solution of 2-nitrobenzhydroxamic chloride (17.7 g) in tetrahydrofuran (100 ml) dropwise over 2 hours. The reaction mixture was heated under feflux for 1 hour and then evaporated. The residue was partitioned between 3n hydrochloric acid, 10% sodium carbonate solution, saturated sodium chloride solution, dried over anhydrous magnesium sulfate, filtered, and the filtrate was evaporated. The residue was chromatographed on silica gel with ethyl acetate as the eluent. The appropriate fractions were collected and evaporated. The residue was recrystallized from dichloromethane/hexanes to yield 15.0 g (66%) of product, mp 125-127°C.
Analysis Calculated for C13H10N2O4: 60.47%C 3.90%H 10.85%N Found: 60.81 %C 4.13%H 10.88%N REACTION SCHEME A wherein R , R , and X are as hereinbef oredef ined .
Claims (2)
1. A compound of the formula 6 wherein X is hydrogen, loweralkyl, halogen, loweralkoxy, hydroxy, or trifluoromethyl, the geometric or optical isomers thereof, N-oxides, thereof or the pharmaceutically acceptable acid addition salts thereof.
2. 6,7-dihydro-3-(2- Nitrophenyl) -1 ,2-benzisoxazole-4(5H)-one.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/654,691 US5210087A (en) | 1991-02-13 | 1991-02-13 | 9-aminotetrahydroacridines and related compounds |
IL10092192A IL100921A (en) | 1991-02-13 | 1992-02-11 | 9-Aminotetra - hydroacridinediols and related compounds process for their preparation intermediates therefor and pharmaceutical compositions containging them |
Publications (1)
Publication Number | Publication Date |
---|---|
IL117795A true IL117795A (en) | 1998-01-04 |
Family
ID=24625869
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10092192A IL100921A (en) | 1991-02-13 | 1992-02-11 | 9-Aminotetra - hydroacridinediols and related compounds process for their preparation intermediates therefor and pharmaceutical compositions containging them |
IL117795A IL117795A (en) | 1991-02-13 | 1992-02-11 | 6, 7-dihydro-3-(2-nitrophenyl) 1, 2-benzisoxazole-4(5h)-ones and pharmaceutically acceptable addition salts thereof |
IL11779596A IL117795A0 (en) | 1991-02-13 | 1996-04-02 | Dihydrobenzisoxazolines |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10092192A IL100921A (en) | 1991-02-13 | 1992-02-11 | 9-Aminotetra - hydroacridinediols and related compounds process for their preparation intermediates therefor and pharmaceutical compositions containging them |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11779596A IL117795A0 (en) | 1991-02-13 | 1996-04-02 | Dihydrobenzisoxazolines |
Country Status (25)
Country | Link |
---|---|
US (3) | US5210087A (en) |
EP (1) | EP0499231B1 (en) |
JP (1) | JPH07121915B2 (en) |
KR (1) | KR100223132B1 (en) |
AT (1) | ATE153331T1 (en) |
AU (1) | AU664165B2 (en) |
BR (1) | BR9200475A (en) |
CA (1) | CA2061084A1 (en) |
CZ (1) | CZ281927B6 (en) |
DE (1) | DE69219801T2 (en) |
DK (1) | DK0499231T3 (en) |
ES (1) | ES2102417T3 (en) |
FI (2) | FI96308C (en) |
GR (1) | GR3024310T3 (en) |
HU (1) | HU219451B (en) |
IE (1) | IE920459A1 (en) |
IL (3) | IL100921A (en) |
MX (1) | MX9200607A (en) |
NO (1) | NO177933C (en) |
NZ (3) | NZ270647A (en) |
PL (6) | PL168153B1 (en) |
RO (1) | RO112354B1 (en) |
RU (1) | RU2083564C1 (en) |
TW (1) | TW221426B (en) |
ZA (1) | ZA921004B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5210087A (en) * | 1991-02-13 | 1993-05-11 | Hoechst-Roussel Pharmaceuticals Inc. | 9-aminotetrahydroacridines and related compounds |
ES2059263B1 (en) * | 1992-10-27 | 1995-10-01 | Vita Invest Sa | PROCEDURE FOR OBTAINING THE (+) - 9-AMINO-1,2,3,4-TETRAHIDROACRIDIN-1-OL. |
US5434170A (en) * | 1993-12-23 | 1995-07-18 | Andrulis Pharmaceuticals Corp. | Method for treating neurocognitive disorders |
ES2144353B1 (en) * | 1997-12-26 | 2001-01-01 | Consejo Superior Investigacion | NEW TACRINE ANALOGS: POTENTIAL NEUROPROTECTING AGENTS FOR ALZHEIMER AND PARKINSON DISEASES. YOUR OBTAINING PROCEDURE. |
JP4544864B2 (en) * | 2002-03-08 | 2010-09-15 | 独立行政法人科学技術振興機構 | Isoxazole derivative and method for producing the same |
RU2616247C1 (en) * | 2016-03-28 | 2017-04-13 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Северо-Осетинский государственный университет имени Коста Левановича Хетагурова" (СОГУ) | Solid dosage forms with choline-positive action based on 9-butylamino-3,3-dimethyl-1,2,4-trihydroacridine |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3232945A (en) * | 1962-08-13 | 1966-02-01 | S E Massengill Company | 7,8,9,10-tetrahalo-6h-cyclohepta-(b)-quinolines |
EP0179383B1 (en) * | 1984-10-25 | 1991-05-29 | Hoechst-Roussel Pharmaceuticals Incorporated | 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds, a process for their preparation and their use as medicaments |
US4695573A (en) * | 1984-10-25 | 1987-09-22 | Hoechst-Roussel Pharmaceuticals Inc. | 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds |
US4631286A (en) * | 1984-10-25 | 1986-12-23 | Hoechst-Roussel Pharmaceuticals Inc. | 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds |
IL87861A0 (en) * | 1987-10-05 | 1989-03-31 | Pfizer | 4-aminopyridine derivatives |
WO1989002739A1 (en) * | 1987-10-05 | 1989-04-06 | Pfizer Inc. | 4-aminopyridine derivatives |
GB8827704D0 (en) * | 1988-11-28 | 1988-12-29 | Fujisawa Pharmaceutical Co | New acridine derivatives & processes for their production |
US5441727A (en) * | 1989-06-21 | 1995-08-15 | The Procter & Gamble Company | Diketone deodorant composition and method of deodorization |
US5053513A (en) * | 1990-03-29 | 1991-10-01 | Hoechst-Roussel Pharmaceuticals Incorporated | Method of reducing a carbonyl containing acridine |
US5210087A (en) * | 1991-02-13 | 1993-05-11 | Hoechst-Roussel Pharmaceuticals Inc. | 9-aminotetrahydroacridines and related compounds |
GB2264707A (en) * | 1991-06-18 | 1993-09-08 | Roger Michael Marchbanks | Acridine derivatives for treating alzheimer's disease |
-
1991
- 1991-02-13 US US07/654,691 patent/US5210087A/en not_active Expired - Fee Related
-
1992
- 1992-01-30 TW TW081100687A patent/TW221426B/zh active
- 1992-02-10 RO RO92-200124A patent/RO112354B1/en unknown
- 1992-02-11 NZ NZ270647A patent/NZ270647A/en unknown
- 1992-02-11 IL IL10092192A patent/IL100921A/en not_active IP Right Cessation
- 1992-02-11 NZ NZ260694A patent/NZ260694A/en unknown
- 1992-02-11 IL IL117795A patent/IL117795A/en not_active IP Right Cessation
- 1992-02-11 FI FI920566A patent/FI96308C/en active
- 1992-02-11 NZ NZ241586A patent/NZ241586A/en unknown
- 1992-02-12 RU SU5010876/04A patent/RU2083564C1/en not_active IP Right Cessation
- 1992-02-12 KR KR1019920002007A patent/KR100223132B1/en not_active IP Right Cessation
- 1992-02-12 ES ES92102332T patent/ES2102417T3/en not_active Expired - Lifetime
- 1992-02-12 MX MX9200607A patent/MX9200607A/en not_active IP Right Cessation
- 1992-02-12 AU AU10903/92A patent/AU664165B2/en not_active Ceased
- 1992-02-12 EP EP92102332A patent/EP0499231B1/en not_active Expired - Lifetime
- 1992-02-12 PL PL92296319A patent/PL168153B1/en unknown
- 1992-02-12 PL PL92293443A patent/PL169095B1/en unknown
- 1992-02-12 PL PL92296320A patent/PL166939B1/en unknown
- 1992-02-12 JP JP4024914A patent/JPH07121915B2/en not_active Expired - Fee Related
- 1992-02-12 ZA ZA921004A patent/ZA921004B/en unknown
- 1992-02-12 BR BR929200475A patent/BR9200475A/en not_active Application Discontinuation
- 1992-02-12 AT AT92102332T patent/ATE153331T1/en not_active IP Right Cessation
- 1992-02-12 DK DK92102332.1T patent/DK0499231T3/en active
- 1992-02-12 CA CA002061084A patent/CA2061084A1/en not_active Abandoned
- 1992-02-12 PL PL92308049A patent/PL168861B1/en unknown
- 1992-02-12 HU HU9200423A patent/HU219451B/en not_active IP Right Cessation
- 1992-02-12 PL PL92308050A patent/PL168906B1/en unknown
- 1992-02-12 NO NO920547A patent/NO177933C/en not_active IP Right Cessation
- 1992-02-12 CZ CS92426A patent/CZ281927B6/en unknown
- 1992-02-12 PL PL92308048A patent/PL168862B1/en unknown
- 1992-02-12 DE DE69219801T patent/DE69219801T2/en not_active Expired - Fee Related
- 1992-02-12 IE IE045992A patent/IE920459A1/en not_active IP Right Cessation
-
1993
- 1993-03-01 US US08/024,037 patent/US5382594A/en not_active Expired - Fee Related
-
1994
- 1994-12-13 FI FI945854A patent/FI97056C/en active
-
1995
- 1995-05-31 US US08/451,327 patent/US5502203A/en not_active Expired - Fee Related
-
1996
- 1996-04-02 IL IL11779596A patent/IL117795A0/en unknown
-
1997
- 1997-07-30 GR GR970401959T patent/GR3024310T3/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2525126B2 (en) | Quinazolinone antianginal agent | |
US4977166A (en) | Benzopyran derivatives and pharmaceutical compositions containing them | |
US4954642A (en) | Forskolin compounds | |
EP0554455B1 (en) | Optically active intermediate and production thereof | |
EP0454501A2 (en) | Benzylidenethiazolidine derivatives, their preparation and their use for the inhibition of lipid peroxides | |
JPS61155358A (en) | Diallylbutyric acid derivative and production thereof | |
CA1310966C (en) | Substituted 1-(h-imidazol-4-yl)alkyl-benzamides | |
EA000831B1 (en) | Novel substituted [2-(1-piperazinyle)etoxy]methyl compounds, method for preparing said compounds and the use thereof | |
IL117795A (en) | 6, 7-dihydro-3-(2-nitrophenyl) 1, 2-benzisoxazole-4(5h)-ones and pharmaceutically acceptable addition salts thereof | |
JPH03204877A (en) | Pyrazolo(1,5-a)pyrimidine derivative | |
PT749438E (en) | NEW SILILOS COMPOUNDS AND THEIR USE | |
EP0002978A2 (en) | Thiazolidinedione-2,4 derivatives, their preparation and pharmaceutical applications | |
IL141920A (en) | Process for the preparation of alkyl mercapto methyl ergoline derivatives and some novel intermediates obtained therewith | |
JPH0670064B2 (en) | Bicyclic imidazole derivative | |
US4757078A (en) | Cyclic aryl hydroxamic acids, derivatives thereof and method of use as anti-allergy agents | |
JPH064641B2 (en) | Method for producing cefalosporin derivative | |
US4599406A (en) | Process for preparing 2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide derivatives and intermediates therefor | |
IE882015L (en) | PRIDYL-PYRROLO £1,2-c| THIAZOLES | |
US4127717A (en) | Benzo-cyclitolamines | |
KR100212584B1 (en) | A method and intermediates for the preparation of 6-fluorobenzisothiazoles | |
KR960016525B1 (en) | Preparation process for dihydropyridine compound or its salt | |
US5567816A (en) | Preparation of acyclovir using 1,3 dioxolane | |
US4317910A (en) | Benzo-cyclitolamines | |
FR2661178A1 (en) | Alkyl 4-[(1,2,3,4-tetrahydro-2-isoquinolyl)methyl]piperidine-1-carboxylate derivatives, their preparation and their application in therapeutics | |
JPS61152676A (en) | Production of dibenzo(b,e)oxepine derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |